Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) trials and registry

Daniel M. Shindler, John B. Kostis, Salim Yusuf, Miguel A. Quinones, Bertram Pitt, Dawn Stewart, Tamara Pinkett, Jalal K. Ghali, Alan C. Wilson

Research output: Contribution to journalArticlepeer-review

373 Scopus citations

Abstract

Diabetes is an independent predictor of morbidity and mortality in SOLVD patients with symptomatic heart failure, asymptomatic left ventricular dysfunction (defined as an ejection fraction of ≤35%), and in a broader Registry population with less stringent entry criteria. It remains a significant predictor of outcome even after adjusting for treatment with enalapril.

Original languageEnglish (US)
Pages (from-to)1017-1020
Number of pages4
JournalAmerican Journal of Cardiology
Volume77
Issue number11
DOIs
StatePublished - May 1 1996

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) trials and registry'. Together they form a unique fingerprint.

Cite this